Search
 
Trial #NCT01000727
Acute Coronary Syndrome Clinical Trials

The Stabilization Of pLaques usIng Darapladib-Thrombolysis In Myocardial Infarction 52 Trial


A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects Following Acute Coronary Syndrome to Compare the Incidence of Major Adverse Cardiovascular Events (MACE).
Study ID: 480848/033; Source: GlaxoSmithKline
Share this page Send to friend
Other clinical trials

Definitions
Interventional trials
Determine whether experimental treatments or new ways of using known therapies are safe and effective under controlled environments.
Observational trials
Address health issues in large groups of people or populations in natural settings.
Recruiting
Participants are currently being recruited and enrolled.
Active, not recruiting
Study is ongoing (i.e., patients are being treated or examined), but enrollment has completed.
Not yet recruiting
Participants are not yet being recruited or enrolled.
Enrolling by invitation
Participants are being (or will be) selected from a predetermined population.
Completed
The study has concluded normally; participants are no longer being examined or treated (i.e., last patient's last visit has occurred).
Withdrawn
Study halted prematurely, prior to enrollment of first participant.
Suspended
Recruiting or enrolling participants has halted prematurely but potentially will resume.
Terminated
Recruiting or enrolling participants has halted prematurely and will not resume; participants are no longer being examined or treated.
Status Active, not recruiting
Country Multiple Countries
Study type Interventional
Enrollment 13000
Start date December 2009
Completion date March 2014
Phase Phase 3
Sponsor GlaxoSmithKline
Summary:
This study will test whether darapladib can safely lower the chances of having a
cardiovascular event (such as a heart attack or stroke) when treatment is started within 30
days after an acute coronary syndrome (also called ACS).
Description:
Subjects who qualify for the study will be randomized 1:1 to either darapladib or placebo
administered in addition to standard therapy. Following the baseline visit, subjects will
be expected to return for clinic visits at 1 month, 3 months, 6 months and every 6 months
until the end of the study.
Eligibility:
Gender: Both
Age: 18 Years - N/A
Inclusion Criteria:
- Signed written informed consent.
- Men or women at least 18 years old (in Taiwan, at least 20 years old). Women must be post-menopausal or using a highly effective method for avoidance of pregnancy.
- Hospitalization for acute coronary syndrome (ACS) within 30 days prior to study entry.
- Clinically stable for 24 hours prior to study entry.
- A planned percutaneous coronary intervention (PCI) should be performed prior to study entry, whenever possible.
- At least one of the following:
- At least 60 years old.
- Myocardial infarction prior to the qualifying ACS event.
- Diabetes mellitus requiring treatment with medication.
- Diagnosed mild or moderate reduction in kidney function.
- Cerebrovascular disease (carotid artery disease or ischemic stroke more than 3 months prior to study entry) OR peripheral artery disease.
Exclusion Criteria:
- ACS symptoms or lab results not believed to be caused by a narrowing or blocked coronary artery.
- No major coronary artery with a blockage of more than 50% (unless all stenoses are successfully treated by PCI).
- Planned coronary artery bypass graft (CABG) surgery, or CABG surgery performed after the qualifying ACS event and prior to study entry.
- Certain types of liver disease.
- Severe reduction in kidney function OR removal of a kidney OR kidney transplant.
- Severe heart failure.
- Blood pressure higher than normal despite lifestyle changes and treatment with medications.
- Any life-threatening disease with a life expectancy of less than 2 years (other than heart disease) that may prevent the subject from completing the study.
- Severe asthma that is poorly controlled with medication.
- Pregnancy (Note: A pregnancy test will be performed on all non-sterile women prior to study entry).
- Previous severe allergic reaction to food, medications, drink, insect stings, etc.
- Drug or alcohol abuse within the past 6 months. Mental/psychological impairment that may prevent the subject from complying with study procedures or understanding the goal and potential risks of participating in the study.
- Certain medications that may interfere with the study medication (these will be identified by the study doctor).
- If both birth parents are at least 50% Japanese, Chinese, or Korean ancestry, must have a blood sample collected for Lp-PLA2 activity. Those with Lp-PLA2 activity less than or equal to 20.0 nmol/min/mL are excluded.
- Previously took darapladib (SB-480848).
- Participation in a study of an investigational medication within the past 30 days.
- Current participation in a study of an investigational device.
- Any other reason the investigator deems the subject should not participate in the study.
Outcome:
Primary outcome
  • Time to the first occurrence of any component of the composite of Major Adverse Cardiovascular Events [MACE: CV death (death due to a cardiovascular cause), non-fatal myocardial infarction, non-fatal stroke].
    Time frame: Through the end of the study.
Secondary outcome
  • All cause mortality.
    Time frame: Through the end of the study.
  • The composite measure of major coronary events that include the first occurrence of coronary heart disease death, non-fatal myocardial infarction or urgent coronary revascularization for myocardial ischemia.
    Time frame: Through the end of the study.
  • The composite measure of total coronary events that include the first occurrence of coronary heart disease death, non-fatal MI, hospitalization for UA, or any coronary revasc procedure (excluding PCI planned prior to but performed after randomization).
    Time frame: Through the end of the study.
  • The first occurrence of any component of the composite of all-cause mortality, non-fatal myocardial infarction, or non-fatal stroke.
    Time frame: Through the end of the study.
  • The individual components of MACE [cardiovascular death, myocardial infarction (fatal and non-fatal), stroke (fatal and non-fatal)].
    Time frame: Through the end of the study.
Contacts:
  • GSK Clinical Trials; GlaxoSmithKline (Study Director)
Location Country Status
GSK Investigational Site Birmingham, Alabama United States
GSK Investigational Site Birmingham, Alabama United States
GSK Investigational Site Huntsville, Alabama United States
GSK Investigational Site Mobile, Alabama United States
GSK Investigational Site Mobile, Alabama United States
GSK Investigational Site Anchorage, Alaska United States
GSK Investigational Site Cottonwood, Arizona United States
GSK Investigational Site Glendale, Arizona United States
GSK Investigational Site Tucson, Arizona United States
GSK Investigational Site Tucson, Arizona United States
GSK Investigational Site Tucson, Arizona United States
GSK Investigational Site Fort Smith, Arkansas United States
GSK Investigational Site Jonesboro, Arkansas United States
GSK Investigational Site Little Rock, Arkansas United States
GSK Investigational Site Bakersfield, California United States
GSK Investigational Site Bakersfield, California United States
GSK Investigational Site Beverly Hills, California United States
GSK Investigational Site Fresno, California United States
GSK Investigational Site Glendale, California United States
GSK Investigational Site La Mesa, California United States
GSK Investigational Site Lomita, California United States
GSK Investigational Site Los Alamitos, California United States
GSK Investigational Site Los Angeles, California United States
GSK Investigational Site Los Angeles, California United States
GSK Investigational Site Mission Hills, California United States
GSK Investigational Site Roseville, California United States
GSK Investigational Site Sacramento, California United States
GSK Investigational Site San Diego, California United States
GSK Investigational Site Santa Ana, California United States
GSK Investigational Site Santa Ana, California United States
GSK Investigational Site Stockton, California United States
GSK Investigational Site Torrance, California United States
GSK Investigational Site Ventura, California United States
GSK Investigational Site Westlake Village, California United States
GSK Investigational Site Colorado Springs, Colorado United States
GSK Investigational Site Golden, Colorado United States
GSK Investigational Site Greeley, Colorado United States
GSK Investigational Site Littleton, Colorado United States
GSK Investigational Site Wheat Ridge, Colorado United States
GSK Investigational Site Bridgeport, Connecticut United States
GSK Investigational Site Bridgeport, Connecticut United States
GSK Investigational Site Guilford, Connecticut United States
GSK Investigational Site Hartford, Connecticut United States
GSK Investigational Site Atlantis, Florida United States
GSK Investigational Site Aventura, Florida United States
GSK Investigational Site Brandon, Florida United States
GSK Investigational Site Clearwater, Florida United States
GSK Investigational Site Daytona Beach, Florida United States
GSK Investigational Site Daytona Beach, Florida United States
GSK Investigational Site Fleming Island, Florida United States
GSK Investigational Site Fort Lauderdale, Florida United States
GSK Investigational Site Gainesville, Florida United States
GSK Investigational Site Gulf Breeze, Florida United States
GSK Investigational Site Hollywood, Florida United States
GSK Investigational Site Inverness, Florida United States
GSK Investigational Site Jacksonville, Florida United States
GSK Investigational Site Jacksonville, Florida United States
GSK Investigational Site Jacksonville, Florida United States
GSK Investigational Site Jacksonville Beach, Florida United States
GSK Investigational Site Jupiter, Florida United States
GSK Investigational Site Kissimmee, Florida United States
GSK Investigational Site Miramar, Florida United States
GSK Investigational Site Ocala, Florida United States
GSK Investigational Site Palm Beach Gardens, Florida United States
GSK Investigational Site Pensacola, Florida United States
GSK Investigational Site Plantation, Florida United States
GSK Investigational Site Port Charlotte, Florida United States
GSK Investigational Site Safety Harbor, Florida United States
GSK Investigational Site Sarasota, Florida United States
GSK Investigational Site St. Petersburg, Florida United States
GSK Investigational Site Tallahassee, Florida United States
GSK Investigational Site Trinity, Florida United States
GSK Investigational Site Vero Beach, Florida United States
GSK Investigational Site Wellington, Florida United States
GSK Investigational Site Atlanta, Georgia United States
GSK Investigational Site Augusta, Georgia United States
GSK Investigational Site Cumming, Georgia United States
GSK Investigational Site Boise, Idaho United States
GSK Investigational Site Aurora, Illinois United States
GSK Investigational Site Bannockburn, Illinois United States
GSK Investigational Site Chicago, Illinois United States
GSK Investigational Site Melrose Park, Illinois United States
GSK Investigational Site Mokena, Illinois United States
GSK Investigational Site North Chicago, Illinois United States
GSK Investigational Site Oakbrook Terrace, Illinois United States
GSK Investigational Site Park Ridge, Illinois United States
GSK Investigational Site Peoria, Illinois United States
GSK Investigational Site Rock Island, Illinois United States
GSK Investigational Site Avon, Indiana United States
GSK Investigational Site Fort Wayne, Indiana United States
GSK Investigational Site Hammond, Indiana United States
GSK Investigational Site Indianapolis, Indiana United States
GSK Investigational Site Indianapolis, Indiana United States
GSK Investigational Site Muncie, Indiana United States
GSK Investigational Site Munster, Indiana United States
GSK Investigational Site South Bend, Indiana United States
GSK Investigational Site Valparaiso, Indiana United States
GSK Investigational Site Iowa City, Iowa United States
GSK Investigational Site West Des Moines, Iowa United States
GSK Investigational Site Crestview Hill, Kentucky United States
GSK Investigational Site Lexington, Kentucky United States
GSK Investigational Site Louisville, Kentucky United States
GSK Investigational Site Louisville, Kentucky United States
GSK Investigational Site Alexandria, Louisiana United States
GSK Investigational Site Lafayette, Louisiana United States
GSK Investigational Site Lake Charles, Louisiana United States
GSK Investigational Site Shreveport, Louisiana United States
GSK Investigational Site Bangor, Maine United States
GSK Investigational Site Lewiston, Maine United States
GSK Investigational Site Scarborough, Maine United States
GSK Investigational Site Baltimore, Maryland United States
GSK Investigational Site Baltimore, Maryland United States
GSK Investigational Site Baltimore, Maryland United States
GSK Investigational Site Baltimore, Maryland United States
GSK Investigational Site Baltimore, Maryland United States
GSK Investigational Site Bel Air, Maryland United States
GSK Investigational Site Columbia, Maryland United States
GSK Investigational Site Salisbury, Maryland United States
GSK Investigational Site Townson, Maryland United States
GSK Investigational Site Towson, Maryland United States
GSK Investigational Site Ayer, Massachusetts United States
GSK Investigational Site Boston, Massachusetts United States
GSK Investigational Site Boston, Massachusetts United States
GSK Investigational Site Fall River, Massachusetts United States
GSK Investigational Site Springfield, Massachusetts United States
GSK Investigational Site Worcester, Massachusetts United States
GSK Investigational Site Ann Arbor, Michigan United States
GSK Investigational Site Dearborn, Michigan United States
GSK Investigational Site Detroit, Michigan United States
GSK Investigational Site Flint, Michigan United States
GSK Investigational Site Kalamazoo, Michigan United States
GSK Investigational Site Marquette, Michigan United States
GSK Investigational Site Pontiac, Michigan United States
GSK Investigational Site Troy, Michigan United States
GSK Investigational Site Ypsilanti, Michigan United States
GSK Investigational Site Duluth, Minnesota United States
GSK Investigational Site Minneapolis, Minnesota United States
GSK Investigational Site Robbinsdale, Minnesota United States
GSK Investigational Site Saint Paul, Minnesota United States
GSK Investigational Site St Cloud, Minnesota United States
GSK Investigational Site Tupelo, Mississippi United States
GSK Investigational Site Columbia, Missouri United States
GSK Investigational Site Joplin, Missouri United States
GSK Investigational Site kansas City, Missouri United States
GSK Investigational Site Springfield, Missouri United States
GSK Investigational Site St Louis, Missouri United States
GSK Investigational Site St.Louis, Missouri United States
GSK Investigational Site Columbia, Montana United States
GSK Investigational Site Great Falls, Montana United States
GSK Investigational Site Kalispell, Montana United States
GSK Investigational Site Grand Island, Nebraska United States
GSK Investigational Site Lincoln, Nebraska United States
GSK Investigational Site Omaha, Nebraska United States
GSK Investigational Site Papillion, Nebraska United States
GSK Investigational Site Las Vegas, Nevada United States
GSK Investigational Site Browns Mills, New Jersey United States
GSK Investigational Site Cherry Hill, New Jersey United States
GSK Investigational Site Elizabeth, New Jersey United States
GSK Investigational Site Elmer, New Jersey United States
GSK Investigational Site Haddon Heights, New Jersey United States
GSK Investigational Site Linden, New Jersey United States
GSK Investigational Site Paterson, New Jersey United States
GSK Investigational Site Pomona, New Jersey United States
GSK Investigational Site Sewell, New Jersey United States
GSK Investigational Site Somerset, New Jersey United States
GSK Investigational Site Summit, New Jersey United States
GSK Investigational Site West Orange, New Jersey United States
GSK Investigational Site Albuquerque, New Mexico United States
GSK Investigational Site Albany, New York United States
GSK Investigational Site Bronx, New York United States
GSK Investigational Site Brooklyn, New York United States
GSK Investigational Site Buffalo, New York United States
GSK Investigational Site Cortlandt Manor, New York United States
GSK Investigational Site New York, New York United States
GSK Investigational Site New York, New York United States
GSK Investigational Site New York, New York United States
GSK Investigational Site Roslyn, New York United States
GSK Investigational Site Stony Brook, New York United States
GSK Investigational Site Syracuse, New York United States
GSK Investigational Site Troy, New York United States
GSK Investigational Site Williamsville, New York United States
GSK Investigational Site Asheville, North Carolina United States
GSK Investigational Site Burlington, North Carolina United States
GSK Investigational Site Charlotte, North Carolina United States
GSK Investigational Site Concord, North Carolina United States
GSK Investigational Site Gastonia, North Carolina United States
GSK Investigational Site Greensboro, North Carolina United States
GSK Investigational Site Huntersville, North Carolina United States
GSK Investigational Site Matthews, North Carolina United States
GSK Investigational Site Monroe, North Carolina United States
GSK Investigational Site Pinehurst, North Carolina United States
GSK Investigational Site Raleigh, North Carolina United States
GSK Investigational Site Rocky Mount, North Carolina United States
GSK Investigational Site Salisbury, North Carolina United States
GSK Investigational Site Sanford, North Carolina United States
GSK Investigational Site Winston-Salem, North Carolina United States
GSK Investigational Site Grand Forks, North Dakota United States
GSK Investigational Site Canton, Ohio United States
GSK Investigational Site Cincinnati, Ohio United States
GSK Investigational Site Cincinnati, Ohio United States
GSK Investigational Site Cleveland, Ohio United States
GSK Investigational Site Dayton, Ohio United States
GSK Investigational Site Elyria, Ohio United States
GSK Investigational Site Fairfield, Ohio United States
GSK Investigational Site Fairview Park, Ohio United States
GSK Investigational Site Lorain, Ohio United States
GSK Investigational Site Mansfield, Ohio United States
GSK Investigational Site Middleburg Heights, Ohio United States
GSK Investigational Site Sandusky, Ohio United States
GSK Investigational Site Toledo, Ohio United States
GSK Investigational Site Toledo, Ohio United States
GSK Investigational Site Youngstown, Ohio United States
GSK Investigational Site Zaneville, Ohio United States
GSK Investigational Site Midwest City, Oklahoma United States
GSK Investigational Site Oklahoma, Oklahoma United States
GSK Investigational Site Oklahoma City, Oklahoma United States
GSK Investigational Site Portland, Oregon United States
GSK Investigational Site Portland, Oregon United States
GSK Investigational Site Allentown, Pennsylvania United States
GSK Investigational Site Beaver, Pennsylvania United States
GSK Investigational Site Bethlehem, Pennsylvania United States
GSK Investigational Site Camp Hill, Pennsylvania United States
GSK Investigational Site Chambersburg, Pennsylvania United States
GSK Investigational Site Doylestown, Pennsylvania United States
GSK Investigational Site Erie, Pennsylvania United States
GSK Investigational Site Hershey, Pennsylvania United States
GSK Investigational Site Jenkintown, Pennsylvania United States
GSK Investigational Site Jersey Shore, Pennsylvania United States
GSK Investigational Site Lancaster, Pennsylvania United States
GSK Investigational Site Landsdale, Pennsylvania United States
GSK Investigational Site Leetsdale, Pennsylvania United States
GSK Investigational Site Philadelphia, Pennsylvania United States
GSK Investigational Site Pittsburgh, Pennsylvania United States
GSK Investigational Site Pittsburgh, Pennsylvania United States
GSK Investigational Site Sayre, Pennsylvania United States
GSK Investigational Site Scranton, Pennsylvania United States
GSK Investigational Site Sellersville, Pennsylvania United States
GSK Investigational Site West Chester, Pennsylvania United States
GSK Investigational Site York, Pennsylvania United States
GSK Investigational Site Charleston, South Carolina United States
GSK Investigational Site Charleston, South Carolina United States
GSK Investigational Site Columbia, South Carolina United States
GSK Investigational Site Greenville, South Carolina United States
GSK Investigational Site Rapid City, South Dakota United States
GSK Investigational Site Chattanooga, Tennessee United States
GSK Investigational Site Columbia, Tennessee United States
GSK Investigational Site Jackson, Tennessee United States
GSK Investigational Site Jackson, Tennessee United States
GSK Investigational Site Johnson City, Tennessee United States
GSK Investigational Site Nashville, Tennessee United States
GSK Investigational Site Oak Ridge, Tennessee United States
GSK Investigational Site Amarillo, Texas United States
GSK Investigational Site Austin, Texas United States
GSK Investigational Site Corpus Christi/Texas, Texas United States
GSK Investigational Site Dallas, Texas United States
GSK Investigational Site Dallas, Texas United States
GSK Investigational Site Fort Worth, Texas United States
GSK Investigational Site Galveston, Texas United States
GSK Investigational Site Harker Heights, Texas United States
GSK Investigational Site Houston, Texas United States
GSK Investigational Site Houston, Texas United States
GSK Investigational Site Houston, Texas United States
GSK Investigational Site Houston, Texas United States
GSK Investigational Site Katy, Texas United States
GSK Investigational Site Kingwood, Texas United States
GSK Investigational Site Round Rock, Texas United States
GSK Investigational Site San Antonio, Texas United States
GSK Investigational Site San Marcos, Texas United States
GSK Investigational Site Sugar Land, Texas United States
GSK Investigational Site Tyler, Texas United States
GSK Investigational Site Victoria, Texas United States
GSK Investigational Site Lynchburg, Virginia United States
GSK Investigational Site Midlothian, Virginia United States
GSK Investigational Site Richmond, Virginia United States
GSK Investigational Site Richmond, Virginia United States
GSK Investigational Site Richmond, Virginia United States
GSK Investigational Site Winchester, Virginia United States
GSK Investigational Site Bellevue, Washington United States
GSK Investigational Site Bellingham, Washington United States
GSK Investigational Site Burien, Washington United States
GSK Investigational Site Everett, Washington United States
GSK Investigational Site Kirkland, Washington United States
GSK Investigational Site Spokane, Washington United States
GSK Investigational Site Spokane, Washington United States
GSK Investigational Site Tacoma, Washington United States
GSK Investigational Site Walla Walla, Washington United States
GSK Investigational Site Beloit, Wisconsin United States
GSK Investigational Site Green Bay, Wisconsin United States
GSK Investigational Site Madison, Wisconsin United States
GSK Investigational Site Wausau, Wisconsin United States
GSK Investigational Site Capital Federal, Buenos Aires Argentina
GSK Investigational Site Ciudad Autonoma de Buenos Aires, Buenos Aires Argentina
GSK Investigational Site Ciudad Autonoma de Buenos Aires, Buenos Aires Argentina
GSK Investigational Site Mar del Plata, Buenos Aires Argentina
GSK Investigational Site Ramos Mejia, Buenos Aires Argentina
GSK Investigational Site San Justo, Buenos Aires Argentina
GSK Investigational Site San Nicolas, Buenos Aires Argentina
GSK Investigational Site Cordoba, Córdova Argentina
GSK Investigational Site Cordoba, Córdova Argentina
GSK Investigational Site Rosario, Santa Fe Argentina
GSK Investigational Site Rosario, Santa Fe Argentina
GSK Investigational Site Rosario, Santa Fe Argentina
GSK Investigational Site Rosario, Santa Fe Argentina
GSK Investigational Site Rosario, Santa Fe Argentina
GSK Investigational Site Buenos Aires, Argentina
GSK Investigational Site Cipolletti, Argentina
GSK Investigational Site Ciudad Autonoma de Buenos Aires, Argentina
GSK Investigational Site Corrientes, Argentina
GSK Investigational Site Haedo, Buenos Aires, Argentina
GSK Investigational Site San Miguel de Tucuman, Argentina
GSK Investigational Site Santa fe, Argentina
GSK Investigational Site Sante Fe, Argentina
GSK Investigational Site Sante Fe, Argentina
GSK Investigational Site Tucuman, Argentina
GSK Investigational Site Zárate, Argentina
GSK Investigational Site Garran, Australian Capital Territory Australia
GSK Investigational Site Camperdown, New South Wales Australia
GSK Investigational Site Gosford, New South Wales Australia
GSK Investigational Site Auchenflower, Queensland Australia
GSK Investigational Site Herston, Queensland Australia
GSK Investigational Site Milton, Queensland Australia
GSK Investigational Site Adelaide, South Australia Australia
GSK Investigational Site Elizabeth Vale, South Australia Australia
GSK Investigational Site Hobart, Tasmania Australia
GSK Investigational Site Box Hill, Victoria Australia
GSK Investigational Site Nedlands, Victoria Australia
GSK Investigational Site Fremantle, Western Australia Australia
GSK Investigational Site Ashford, Australia
GSK Investigational Site Aalst, Belgium
GSK Investigational Site Bonheiden, Belgium
GSK Investigational Site Brussels, Belgium
GSK Investigational Site Brussels, Belgium
GSK Investigational Site Bruxelles, Belgium
GSK Investigational Site Edegem, Belgium
GSK Investigational Site Genk, Belgium
GSK Investigational Site La Louvière, Belgium
GSK Investigational Site Leuven, Belgium
GSK Investigational Site Liège, Belgium
GSK Investigational Site Roeselaere, Belgium
GSK Investigational Site Salvador, Bahía Brazil
GSK Investigational Site Fortaleza, Ceará Brazil
GSK Investigational Site Goiânia - GO, Goiás Brazil
GSK Investigational Site Belo Horizonte, Minas Gerais Brazil
GSK Investigational Site Belo Horizonte, Minas Gerais Brazil
GSK Investigational Site Campina Grande do Sul, Paraná Brazil
GSK Investigational Site Curitiba, Paraná Brazil
GSK Investigational Site Pelotas, Rio Grande Do Sul Brazil
GSK Investigational Site Porto Alegre, Rio Grande Do Sul Brazil
GSK Investigational Site Porto Alegre, Rio Grande Do Sul Brazil
GSK Investigational Site Porto Alegre, Rio Grande Do Sul Brazil
GSK Investigational Site Porto Alegre, Rio Grande Do Sul Brazil
GSK Investigational Site Porto Alegre, Rio Grande Do Sul Brazil
GSK Investigational Site Porto Alegre, Rio Grande Do Sul Brazil
GSK Investigational Site Natal, Rio Grande Du Norte Brazil
GSK Investigational Site Marília, São Paulo Brazil
GSK Investigational Site Sao Jose do Rio Preto, São Paulo Brazil
GSK Investigational Site Sao Paulo, São Paulo Brazil
GSK Investigational Site São José do Rio Preto, São Paulo Brazil
GSK Investigational Site Votuporanga, São Paulo Brazil
GSK Investigational Site Bahia, Brazil
GSK Investigational Site Brasília, Brazil
GSK Investigational Site Campinas, Brazil
GSK Investigational Site Campo Grande, Brazil
GSK Investigational Site Rio De Janeiro, Brazil
GSK Investigational Site Rio de Janeiro, Brazil
GSK Investigational Site São Paulo, Brazil
GSK Investigational Site São Paulo, Brazil
GSK Investigational Site São Paulo, Brazil
GSK Investigational Site São Paulo - SP, Brazil
GSK Investigational Site Uberlandia, Brazil
GSK Investigational Site Dimitrovgrad, Bulgaria
GSK Investigational Site Haskovo, Bulgaria
GSK Investigational Site Pleven, Bulgaria
GSK Investigational Site Plovdiv, Bulgaria
GSK Investigational Site Plovdiv, Bulgaria
GSK Investigational Site Sofia, Bulgaria
GSK Investigational Site Sofia, Bulgaria
GSK Investigational Site Sofia, Bulgaria
GSK Investigational Site Sofia, Bulgaria
GSK Investigational Site Sofia, Bulgaria
GSK Investigational Site Sofia, Bulgaria
GSK Investigational Site Veliko Tarnovo, Bulgaria
GSK Investigational Site Edmonton, Alberta Canada
GSK Investigational Site Campbell River, British Columbia Canada
GSK Investigational Site New Westminister, British Columbia Canada
GSK Investigational Site Surrey, British Columbia Canada
GSK Investigational Site Vancouver, British Columbia Canada
GSK Investigational Site Victoria, British Columbia Canada
GSK Investigational Site St. John's, Newfoundland and Labrador Canada
GSK Investigational Site Truro, Nova Scotia Canada
GSK Investigational Site Ajax, Ontario Canada
GSK Investigational Site Brampton, Ontario Canada
GSK Investigational Site Cambridge, Ontario Canada
GSK Investigational Site Cambridge, Ontario Canada
GSK Investigational Site Hamilton, Ontario Canada
GSK Investigational Site Kelowna, Ontario Canada
GSK Investigational Site Mississauga, Ontario Canada
GSK Investigational Site Newmarket, Ontario Canada
GSK Investigational Site Oshawa, Ontario Canada
GSK Investigational Site Oshawa, Ontario Canada
GSK Investigational Site Ottawa, Ontario Canada
GSK Investigational Site Sarnia, Ontario Canada
GSK Investigational Site Sudbury, Ontario Canada
GSK Investigational Site Sudbury, Ontario Canada
GSK Investigational Site Thunder Bay, Ontario Canada
GSK Investigational Site Toronto, Ontario Canada
GSK Investigational Site Toronto, Ontario Canada
GSK Investigational Site Greenfield Park, Quebec Canada
GSK Investigational Site Longueuil, Quebec Canada
GSK Investigational Site Montreal, Quebec Canada
GSK Investigational Site Montreal, Quebec Canada
GSK Investigational Site Sherbrooke, Quebec Canada
GSK Investigational Site Thetford Mines, Quebec Canada
GSK Investigational Site Temuco, Región De La Araucania Chile
GSK Investigational Site Concepción, Región Del Biobio Chile
GSK Investigational Site Talcahuano, Región Del Biobio Chile
GSK Investigational Site Santiago, Región Metro De Santiago Chile
GSK Investigational Site Santiago, Región Metro De Santiago Chile
GSK Investigational Site Santiago, Región Metro De Santiago Chile
GSK Investigational Site Viña del Mar, Valparaíso Chile
GSK Investigational Site Santiago, Chile
GSK Investigational Site Santiago, Chile
GSK Investigational Site Temuco, Chile
GSK Investigational Site Lanzhou, Gansu China
GSK Investigational Site Guangzhou, Guangdong China
GSK Investigational Site Guangzhou, Guangdong China
GSK Investigational Site Nanning, Guangxi China
GSK Investigational Site Haikou, Hainan China
GSK Investigational Site Shijiazhuang, Hebei China
GSK Investigational Site Nanjing, Jiangsu China
GSK Investigational Site Dalian, Liaoning China
GSK Investigational Site Shenyang, Liaoning China
GSK Investigational Site Shenyang, Liaoning China
GSK Investigational Site Xian, Shaanxi China
GSK Investigational Site Jinan, Shandong China
GSK Investigational Site Chengdu, Sichuan China
GSK Investigational Site Hangzhou, Zhejiang China
GSK Investigational Site Beijing, China
GSK Investigational Site Beijing, China
GSK Investigational Site Beijing, China
GSK Investigational Site Beijing, China
GSK Investigational Site Beijing, China
GSK Investigational Site Beijing, China
GSK Investigational Site Hangzhou, China
GSK Investigational Site Jinan, China
GSK Investigational Site Shanghai, China
GSK Investigational Site Shanghai, China
GSK Investigational Site Shanghai, China
GSK Investigational Site Suzhou, China
GSK Investigational Site Armenia, Colombia
GSK Investigational Site Barranquilla, Colombia
GSK Investigational Site Bogota, Colombia
GSK Investigational Site Bogota, Colombia
GSK Investigational Site Bogota, Colombia
GSK Investigational Site Bogotá, Colombia
GSK Investigational Site Bucaramanga, Colombia
GSK Investigational Site Cartagena, Colombia
GSK Investigational Site Manizales, Colombia
GSK Investigational Site Medellin, Colombia
GSK Investigational Site Medellín, Colombia
GSK Investigational Site Brno, Czech Republic
GSK Investigational Site Brno, Czech Republic
GSK Investigational Site Brno, Czech Republic
GSK Investigational Site Caslav, Czech Republic
GSK Investigational Site Jihlava, Czech Republic
GSK Investigational Site Kromeriz, Czech Republic
GSK Investigational Site Milevsko, Czech Republic
GSK Investigational Site Olomouc, Czech Republic
GSK Investigational Site Plzen - Bory, Czech Republic
GSK Investigational Site Praha 10, Czech Republic
GSK Investigational Site Praha 2, Czech Republic
GSK Investigational Site Slany, Czech Republic
GSK Investigational Site Svitavy, Czech Republic
GSK Investigational Site Usti nad Orlici, Czech Republic
GSK Investigational Site Zlin, Czech Republic
GSK Investigational Site Aalborg, Denmark
GSK Investigational Site Aarhus, Denmark
GSK Investigational Site Esbjerg, Denmark
GSK Investigational Site Frederikssund, Denmark
GSK Investigational Site Glostrup, Denmark
GSK Investigational Site Hellerup, Denmark
GSK Investigational Site Herlev, Denmark
GSK Investigational Site Holbæk, Denmark
GSK Investigational Site Hvidovre, Denmark
GSK Investigational Site Koebenhavn N, Denmark
GSK Investigational Site Kolding, Denmark
GSK Investigational Site København NV, Denmark
GSK Investigational Site København S, Denmark
GSK Investigational Site Køge, Denmark
GSK Investigational Site Næstved, Denmark
GSK Investigational Site Odense C, Denmark
GSK Investigational Site Roskilde, Denmark
GSK Investigational Site Silkeborg, Denmark
GSK Investigational Site Svendborg, Denmark
GSK Investigational Site Pau, Aquitaine France
GSK Investigational Site Langres, Champagne-Ardenne France
GSK Investigational Site Dunkerque, Nord-Pas-de-Calais France
GSK Investigational Site Avignon, France
GSK Investigational Site Besançon Cedex, France
GSK Investigational Site Bron, France
GSK Investigational Site Créteil, France
GSK Investigational Site Dijon Cedex, France
GSK Investigational Site Lagny sur Marne, France
GSK Investigational Site Le Plessis Robinson, France
GSK Investigational Site Lille, France
GSK Investigational Site Marseille Cedex 08, France
GSK Investigational Site Montfermeil, France
GSK Investigational Site Paris, France
GSK Investigational Site Paris Cedex 18, France
GSK Investigational Site Poitiers, France
GSK Investigational Site Quincy sous Sénart, France
GSK Investigational Site Rennes, France
GSK Investigational Site Strasbourg Cedex, France
GSK Investigational Site Toulouse, France
GSK Investigational Site Tourcoing, France
GSK Investigational Site Bad Krozingen, Baden-Wuerttemberg Germany
GSK Investigational Site Freiburg, Baden-Wuerttemberg Germany
GSK Investigational Site Heidelberg, Baden-Wuerttemberg Germany
GSK Investigational Site Stuttgart, Baden-Wuerttemberg Germany
GSK Investigational Site Ulm, Baden-Wuerttemberg Germany
GSK Investigational Site Muenchen, Bayern Germany
GSK Investigational Site Muenchen, Bayern Germany
GSK Investigational Site Bad Nauheim, Hessen Germany
GSK Investigational Site Darmstadt, Hessen Germany
GSK Investigational Site Frankfurt, Hessen Germany
GSK Investigational Site Frankfurt, Hessen Germany
GSK Investigational Site Langen, Hessen Germany
GSK Investigational Site Limburg, Hessen Germany
GSK Investigational Site Bad Rothenfelde, Niedersachsen Germany
GSK Investigational Site Hannover, Niedersachsen Germany
GSK Investigational Site Oldenburg, Niedersachsen Germany
GSK Investigational Site Bielefeld, Nordrhein-Westfalen Germany
GSK Investigational Site Eschweiler, Nordrhein-Westfalen Germany
GSK Investigational Site Essen, Nordrhein-Westfalen Germany
GSK Investigational Site Essen, Nordrhein-Westfalen Germany
GSK Investigational Site Neuss, Nordrhein-Westfalen Germany
GSK Investigational Site Wuppertal, Nordrhein-Westfalen Germany
GSK Investigational Site Ludwigshafen, Rheinland-Pfalz Germany
GSK Investigational Site Homburg, Saarland Germany
GSK Investigational Site Kiel, Schleswig-Holstein Germany
GSK Investigational Site Luebeck, Schleswig-Holstein Germany
GSK Investigational Site Altenburg, Thueringen Germany
GSK Investigational Site Berlin, Germany
GSK Investigational Site Berlin, Germany
GSK Investigational Site Berlin, Germany
GSK Investigational Site Bremen, Germany
GSK Investigational Site Halle, Germany
GSK Investigational Site Hamburg, Germany
GSK Investigational Site Budapest, Hungary
GSK Investigational Site Budapest, Hungary
GSK Investigational Site Budapest, Hungary
GSK Investigational Site Budapest, Hungary
GSK Investigational Site Budapest, Hungary
GSK Investigational Site Budapest, Hungary
GSK Investigational Site Budapest, Hungary
GSK Investigational Site Cegléd, Hungary
GSK Investigational Site Eger, Hungary
GSK Investigational Site Gyula, Hungary
GSK Investigational Site Hodmezovasarhely, Hungary
GSK Investigational Site Kistarcsa, Hungary
GSK Investigational Site Miskolc, Hungary
GSK Investigational Site Szolnok, Hungary
GSK Investigational Site Szombathely, Hungary
GSK Investigational Site Székesfehérvár, Hungary
GSK Investigational Site Zalaegerszeg, Hungary
GSK Investigational Site Ahmedabad, India
GSK Investigational Site Ahmedabad, India
GSK Investigational Site Amritsar, India
GSK Investigational Site Chennai, India
GSK Investigational Site Chennai, India
GSK Investigational Site Faridabad, India
GSK Investigational Site Gandhinagar, India
GSK Investigational Site Gurgaon, India
GSK Investigational Site Hyderabad, India
GSK Investigational Site Hyderabad, India
GSK Investigational Site Hyderabad, India
GSK Investigational Site Hyderabad, India
GSK Investigational Site Hyderabad, India
GSK Investigational Site Indore, India
GSK Investigational Site Jaipur, India
GSK Investigational Site Lucknow, India
GSK Investigational Site Mohali, India
GSK Investigational Site New Delhi, India
GSK Investigational Site New Delhi, India
GSK Investigational Site New Delhi, India
GSK Investigational Site Noida, India
GSK Investigational Site Patiala, India
GSK Investigational Site Pune, India
GSK Investigational Site Pune,, India
GSK Investigational Site Secunderabad,, India
GSK Investigational Site Vadodara, India
GSK Investigational Site Visakhapatnam, India
GSK Investigational Site Ashkelon, Israel
GSK Investigational Site Beer Sheva, Israel
GSK Investigational Site Haddera, Israel
GSK Investigational Site Haifa, Israel
GSK Investigational Site Haifa, Israel
GSK Investigational Site Haifa, Israel
GSK Investigational Site Holon, Israel
GSK Investigational Site Jerusalem, Israel
GSK Investigational Site Jerusalem, Israel
GSK Investigational Site Jerusalem, Israel
GSK Investigational Site Jerusalem, Israel
GSK Investigational Site Kfar Saba, Israel
GSK Investigational Site Nahariya, Israel
GSK Investigational Site Poriya, Israel
GSK Investigational Site Raanana, Israel
GSK Investigational Site Ramat-Gan, Israel
GSK Investigational Site Rehovot, Israel
GSK Investigational Site Safed, Israel
GSK Investigational Site Tel Aviv, Israel
GSK Investigational Site Catanzaro, Calabria Italy
GSK Investigational Site Napoli, Campania Italy
GSK Investigational Site Bologna, Emilia-Romagna Italy
GSK Investigational Site Carpi, Emilia-Romagna Italy
GSK Investigational Site Ferrara, Emilia-Romagna Italy
GSK Investigational Site Parma, Emilia-Romagna Italy
GSK Investigational Site Palmanova, Friuli-Venezia-Giulia Italy
GSK Investigational Site San Daniele del Friuli, Friuli-Venezia-Giulia Italy
GSK Investigational Site Udine, Friuli-Venezia-Giulia Italy
GSK Investigational Site Roma, Lazio Italy
GSK Investigational Site Roma, Lazio Italy
GSK Investigational Site Roma, Lazio Italy
GSK Investigational Site Bergamo, Lombardia Italy
GSK Investigational Site Milano, Lombardia Italy
GSK Investigational Site Rozzano (Mi), Lombardia Italy
GSK Investigational Site Ascoli Piceno, Marche Italy
GSK Investigational Site Novara, Piemonte Italy
GSK Investigational Site Sassari, Sardegna Italy
GSK Investigational Site Pisa, Toscana Italy
GSK Investigational Site Treviso, Veneto Italy
GSK Investigational Site Legnano, Italy
GSK Investigational Site Sassuolo, Italy
GSK Investigational Site Chiba, Japan
GSK Investigational Site Fukuoka, Japan
GSK Investigational Site Fukuoka, Japan
GSK Investigational Site Fukuoka, Japan
GSK Investigational Site Hokkaido, Japan
GSK Investigational Site Hokkaido, Japan
GSK Investigational Site Hokkaido, Japan
GSK Investigational Site Hyogo, Japan
GSK Investigational Site Kanagawa, Japan
GSK Investigational Site Kanagawa, Japan
GSK Investigational Site Kanagawa, Japan
GSK Investigational Site Kyoto, Japan
GSK Investigational Site Nagasaki, Japan
GSK Investigational Site Oita, Japan
GSK Investigational Site Okayama, Japan
GSK Investigational Site Osaka, Japan
GSK Investigational Site Osaka, Japan
GSK Investigational Site Osaka, Japan
GSK Investigational Site Saga, Japan
GSK Investigational Site Shizuoka, Japan
GSK Investigational Site Tokyo, Japan
GSK Investigational Site Tokyo, Japan
GSK Investigational Site Tokyo, Japan
GSK Investigational Site Tokyo, Japan
GSK Investigational Site Dae-Gu, Korea, Republic of
GSK Investigational Site Daejeon, Korea, Republic of
GSK Investigational Site Gangnam-gu, Seoul, Korea, Republic of
GSK Investigational Site Gwangju, Korea, Republic of
GSK Investigational Site Kangwon-do, Korea, Republic of
GSK Investigational Site Pusan, Korea, Republic of
GSK Investigational Site Seoul, Korea, Republic of
GSK Investigational Site Seoul, Korea, Republic of
GSK Investigational Site Seoul, Korea, Republic of
GSK Investigational Site Seoul, Korea, Republic of
GSK Investigational Site 's-Hertogenbosch, Netherlands
GSK Investigational Site Amersfoort, Netherlands
GSK Investigational Site Amsterdam, Netherlands
GSK Investigational Site Amsterdam, Netherlands
GSK Investigational Site Amsterdam, Netherlands
GSK Investigational Site Apeldoorn, Netherlands
GSK Investigational Site Blaricum, Netherlands
GSK Investigational Site Den Haag, Netherlands
GSK Investigational Site Deventer, Netherlands
GSK Investigational Site Dirksland, Netherlands
GSK Investigational Site Doetinchem, Netherlands
GSK Investigational Site Drachten, Netherlands
GSK Investigational Site Eindhoven, Netherlands
GSK Investigational Site Gorinchem, Netherlands
GSK Investigational Site Gouda, Netherlands
GSK Investigational Site Groningen, Netherlands
GSK Investigational Site Hardenberg, Netherlands
GSK Investigational Site Harderwijk, Netherlands
GSK Investigational Site Heerenveen, Netherlands
GSK Investigational Site Heerlen, Netherlands
GSK Investigational Site Helmond, Netherlands
GSK Investigational Site Hilversum, Netherlands
GSK Investigational Site Hoofddorp, Netherlands
GSK Investigational Site Hoorn, Netherlands
GSK Investigational Site Nijmegen, Netherlands
GSK Investigational Site OSS, Netherlands
GSK Investigational Site Roermond, Netherlands
GSK Investigational Site Rotterdam, Netherlands
GSK Investigational Site Rotterdam, Netherlands
GSK Investigational Site Sittard-geleen, Netherlands
GSK Investigational Site Sneek, Netherlands
GSK Investigational Site Tiel, Netherlands
GSK Investigational Site Tilburg, Netherlands
GSK Investigational Site Veldhoven, Netherlands
GSK Investigational Site Venlo, Netherlands
GSK Investigational Site Zoetermeer, Netherlands
GSK Investigational Site Auckland, New Zealand
GSK Investigational Site Auckland, New Zealand
GSK Investigational Site Christchurch, New Zealand
GSK Investigational Site Dunedin, New Zealand
GSK Investigational Site Hamilton, New Zealand
GSK Investigational Site Lower Hutt, New Zealand
GSK Investigational Site New Plymouth, New Zealand
GSK Investigational Site Palmerston North, New Zealand
GSK Investigational Site Takapuna, Auckland, New Zealand
GSK Investigational Site Tauranga, New Zealand
GSK Investigational Site Whangarei, New Zealand
GSK Investigational Site Miraflores, Lima, Lima Peru
GSK Investigational Site San Martin de Porres, Lima Peru
GSK Investigational Site Callao, Peru
GSK Investigational Site Lima, Peru
GSK Investigational Site Lima, Peru
GSK Investigational Site Lima, Peru
GSK Investigational Site Lima Cercado, Peru
GSK Investigational Site Cebu City, Philippines
GSK Investigational Site Davao, Philippines
GSK Investigational Site Manila, Philippines
GSK Investigational Site Quezon City, Philippines
GSK Investigational Site Quezon City, Philippines
GSK Investigational Site Quezon City, Philippines
GSK Investigational Site Bialystok, Poland
GSK Investigational Site Bydgoszcz, Poland
GSK Investigational Site Bytom, Poland
GSK Investigational Site Chrzanow, Poland
GSK Investigational Site Gdansk, Poland
GSK Investigational Site Gdynia, Poland
GSK Investigational Site Gdynia, Poland
GSK Investigational Site Gdynia, Poland
GSK Investigational Site Inowroclaw, Poland
GSK Investigational Site Krakow, Poland
GSK Investigational Site Krakow, Poland
GSK Investigational Site Lodz, Poland
GSK Investigational Site Lubin, Poland
GSK Investigational Site Mielec, Poland
GSK Investigational Site Olawa, Poland
GSK Investigational Site Opole, Poland
GSK Investigational Site Radom, Poland
GSK Investigational Site Skierniewice, Poland
GSK Investigational Site Tarnow, Poland
GSK Investigational Site Torun, Poland
GSK Investigational Site Tychy, Poland
GSK Investigational Site Walbrzych, Poland
GSK Investigational Site Warsaw, Poland
GSK Investigational Site Warszawa, Poland
GSK Investigational Site Warszawa, Poland
GSK Investigational Site Warszawa, Poland
GSK Investigational Site Wloclawek, Poland
GSK Investigational Site Wroclaw, Poland
GSK Investigational Site Wroclaw, Poland
GSK Investigational Site Wroclaw, Poland
GSK Investigational Site Zamosc, Poland
GSK Investigational Site Zielona Gora, Poland
GSK Investigational Site Baia Mare, Romania
GSK Investigational Site Braila, Romania
GSK Investigational Site Brasov, Romania
GSK Investigational Site Bucharest, Romania
GSK Investigational Site Bucharest, Romania
GSK Investigational Site Bucharest, Romania
GSK Investigational Site Bucharest, Romania
GSK Investigational Site Bucharest, Romania
GSK Investigational Site Bucharest, Romania
GSK Investigational Site Cluj-Napoca, Romania
GSK Investigational Site Constanta, Romania
GSK Investigational Site Craiova, Romania
GSK Investigational Site Iasi, Romania
GSK Investigational Site Targu Mures, Romania
GSK Investigational Site Barnaul, Russian Federation
GSK Investigational Site Ekaterinburg, Russian Federation
GSK Investigational Site Ekaterinburg, Russian Federation
GSK Investigational Site Gatchina, Russian Federation
GSK Investigational Site Kemerovo, Russian Federation
GSK Investigational Site Kemerovo, Russian Federation
GSK Investigational Site Krasnoyarsk, Russian Federation
GSK Investigational Site Moscow, Russian Federation
GSK Investigational Site Moscow, Russian Federation
GSK Investigational Site Moscow, Russian Federation
GSK Investigational Site Moscow, Russian Federation
GSK Investigational Site Moscow, Russian Federation
GSK Investigational Site Moscow, Russian Federation
GSK Investigational Site Moscow, Russian Federation
GSK Investigational Site Moscow, Russian Federation
GSK Investigational Site Moscow, Russian Federation
GSK Investigational Site Moscow, Russian Federation
GSK Investigational Site Nizhniy Novgorod, Russian Federation
GSK Investigational Site Nizhniy Novgorod, Russian Federation
GSK Investigational Site Novosibirsk, Russian Federation
GSK Investigational Site Novosibirsk, Russian Federation
GSK Investigational Site Orenburg, Russian Federation
GSK Investigational Site Samara, Russian Federation
GSK Investigational Site Saratov, Russian Federation
GSK Investigational Site Saratov, Russian Federation
GSK Investigational Site St'Petersburg, Russian Federation
GSK Investigational Site St-Petersburg, Russian Federation
GSK Investigational Site St-Petersburg, Russian Federation
GSK Investigational Site St-Petersburg, Russian Federation
GSK Investigational Site St. Petersburg, Russian Federation
GSK Investigational Site St. Petersburg, Russian Federation
GSK Investigational Site St. Petersburg, Russian Federation
GSK Investigational Site St. Petersburg, Russian Federation
GSK Investigational Site St. Petersburg, Russian Federation
GSK Investigational Site St. Petersburg, Russian Federation
GSK Investigational Site St. Petersburg, Russian Federation
GSK Investigational Site Tomsk, Russian Federation
GSK Investigational Site Tyumen, Russian Federation
GSK Investigational Site Tyumen, Russian Federation
GSK Investigational Site Yaroslavl, Russian Federation
GSK Investigational Site Bratislava, Slovakia
GSK Investigational Site Bratislava, Slovakia
GSK Investigational Site Bratislava, Slovakia
GSK Investigational Site Bratislava, Slovakia
GSK Investigational Site Kosice, Slovakia
GSK Investigational Site Nitra, Slovakia
GSK Investigational Site Nitra, Slovakia
GSK Investigational Site Nove Zamky, Slovakia
GSK Investigational Site Bloemfontein, Free State South Africa
GSK Investigational Site Alberton, Gauteng South Africa
GSK Investigational Site Johannesburg, Gauteng South Africa
GSK Investigational Site Pretoria, Gauteng South Africa
GSK Investigational Site Pretoria, Gauteng South Africa
GSK Investigational Site Durban, KwaZulu- Natal South Africa
GSK Investigational Site Durban, KwaZulu- Natal South Africa
GSK Investigational Site Cape Town, Western Province South Africa
GSK Investigational Site Cape Town, Western Province South Africa
GSK Investigational Site Panorama, Western Province South Africa
GSK Investigational Site Goodwood, South Africa
GSK Investigational Site Kempton Park, South Africa
GSK Investigational Site Paarl, South Africa
GSK Investigational Site Parktown West, South Africa
GSK Investigational Site Parow, South Africa
GSK Investigational Site Pretoria, South Africa
GSK Investigational Site Pretoria, South Africa
GSK Investigational Site Somerset West, South Africa
GSK Investigational Site Worcester, South Africa
GSK Investigational Site Alicante, Spain
GSK Investigational Site Barcelona, Spain
GSK Investigational Site Lerida, Spain
GSK Investigational Site León, Spain
GSK Investigational Site Madrid, Spain
GSK Investigational Site Madrid, Spain
GSK Investigational Site Malaga, Spain
GSK Investigational Site Oviedo, Spain
GSK Investigational Site San Juan/Alicante, Spain
GSK Investigational Site San Sebastián, Spain
GSK Investigational Site San Sebastián de los Reyes/Madrid, Spain
GSK Investigational Site Sevilla, Spain
GSK Investigational Site Valencia, Spain
GSK Investigational Site Vigo/Pontevedra, Spain
GSK Investigational Site Göteborg, Sweden
GSK Investigational Site Göteborg, Sweden
GSK Investigational Site Göteborg, Sweden
GSK Investigational Site Hässleholm, Sweden
GSK Investigational Site Jönköping, Sweden
GSK Investigational Site Stockholm, Sweden
GSK Investigational Site Västerås, Sweden
GSK Investigational Site Örebro, Sweden
GSK Investigational Site Östersund, Sweden
GSK Investigational Site Kaohsiung, Taiwan
GSK Investigational Site Kaohsiung City, Taiwan
GSK Investigational Site Taipei, Taiwan
GSK Investigational Site Taipei, Taiwan
GSK Investigational Site Taipei, Taiwan
GSK Investigational Site Yung Kang City, Taiwan
GSK Investigational Site Bangkok, Thailand
GSK Investigational Site Bangkoknoi, Thailand
GSK Investigational Site Chiangmai, Thailand
GSK Investigational Site Khon Kaen, Muang, Thailand
GSK Investigational Site Nakhon Ratchasima, Thailand
GSK Investigational Site Pathumthani, Thailand
GSK Investigational Site Ankara, Turkey
GSK Investigational Site Erzurum, Turkey
GSK Investigational Site Eskisehir, Turkey
GSK Investigational Site Izmir, Turkey
GSK Investigational Site Izmir, Turkey
GSK Investigational Site Izmir, Turkey
GSK Investigational Site Dnipropetrovsk, Ukraine
GSK Investigational Site Donetsk, Ukraine
GSK Investigational Site Kharkiv, Ukraine
GSK Investigational Site Kharkiv, Ukraine
GSK Investigational Site Kharkiv, Ukraine
GSK Investigational Site Kharkiv, Ukraine
GSK Investigational Site Kyiv, Ukraine
GSK Investigational Site Kyiv, Ukraine
GSK Investigational Site Kyiv, Ukraine
GSK Investigational Site Kyiv, Ukraine
GSK Investigational Site Kyiv, Ukraine
GSK Investigational Site Kyiv, Ukraine
GSK Investigational Site Lugansk, Ukraine
GSK Investigational Site Lutsk, Ukraine
GSK Investigational Site Mykolaiv, Ukraine
GSK Investigational Site Odesa, Ukraine
GSK Investigational Site Simferopol, Ukraine
GSK Investigational Site Vinnytsia, Ukraine
GSK Investigational Site Vinnytsia, Ukraine
GSK Investigational Site Zaporizhzhya, Ukraine
GSK Investigational Site Exeter, Devon United Kingdom
GSK Investigational Site Torquay, Devon United Kingdom
GSK Investigational Site Airdrie, Lanarkshire United Kingdom
GSK Investigational Site Harrow, Middlesex United Kingdom
GSK Investigational Site Northampton, Northamptonshire United Kingdom
GSK Investigational Site Nottingham, Nottinghamshire United Kingdom
GSK Investigational Site Chertsey, Surrey United Kingdom
GSK Investigational Site Coventry, West Midlands United Kingdom
GSK Investigational Site Antrim, United Kingdom
GSK Investigational Site Chichester, United Kingdom
GSK Investigational Site East Kilbride, United Kingdom
GSK Investigational Site Hertfordshire, United Kingdom
GSK Investigational Site Liverpool, United Kingdom
GSK Investigational Site Paisley, United Kingdom
GSK Investigational Site Stirling, United Kingdom
Sponsors:
  • GlaxoSmithKline - (Lead Sponsor)
  • The TIMI Study Group - Collaborator

Related trials: Terms
  • Heart disease
  • Lp-PLA2 inhibitor
  • Acute Coronary Syndrome (ACS)
  • Cardiovascular disease
  • Coronary Heart Disease (CHD)
  • Atherosclerosis
  • The TIMI Study Group
Home  •  Browse by Condition  •  Search Clinical Trials
The information found on this site has been provided by clinicaltrials.gov in accordance with their terms & conditions. Neither we (inclinicaltrials.com), the United States Government, U.S. Department of Health and Human Services, National Institutes of Health, National Library of Medicine, nor any of its agencies, contractors, subcontractors or employees of the United States Government make any warranties, expressed or implied, with respect to data found on this site, and, furthermore, assume no liability, or the results of such use, of any part of the data.